AdvantiGen Biosciences
Biotechnology Research • 
Madison, Wisconsin, United States • 1-10 Employees
Company overview
| Headquarters | 510 Charmany Dr, Madison, Wisconsin 53719, US |
| Phone number | +16082040063 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Inflammation, Monoclonal Antibodies, Immuno-Oncology, T-Cell, Immune Checkpoint Inhibitor (Ici) |
| Founded | 2015 |
| Employees | 1-10 |
| Socials |
Key Contact at AdvantiGen Biosciences
Pascal Longchamp
Chief Executive Officer
AdvantiGen Biosciences Email Formats
AdvantiGen Biosciences uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@advantigenbio.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@advantigenbio.com | 50% |
{first name}{last name} | johndoe@advantigenbio.com | 50% |
About AdvantiGen Biosciences
AdvantiGen has discovered and validated a new Immune-Checkpoint (IC) target on T-cell for Immuno-Oncology; a market forecasted to grow to > $ 155 Billion by 2031. AdvantiGen ADVAN-1 monoclonal antibody (mAbs) program has delivered a set of mAbs modulating the interaction between this new IC target and its ligand(s), thus restoring the ability of the T cell to kill the cancer cells; the hallmark of an Immune Checkpoint Inhibitors (ICI). AdvantiGen has also shown that its novel target interacts with many cancer cell types, hinting at clinical relevance of the target in both solid tumors, such as skin, kidney, breast, colorectal, lung and liver cancers as well as blood cancers, such T cell Lymphoma and AML.
AdvantiGen Biosciences revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
AdvantiGen Biosciences has 3 employees across 2 departments.
Departments
Number of employees
Funding Data
AdvantiGen Biosciences has never raised funding before.
AdvantiGen Biosciences Tech Stack
Discover the technologies and tools that power AdvantiGen Biosciences's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
CDN
Security
JavaScript libraries
Maps
JavaScript libraries
JavaScript frameworks
Security
Analytics
Font scripts
Ecommerce
Netherlands
Singapore
Germany
United Kingdom
South Africa
India
CanadaFrequently asked questions
4.8
40,000 users
